Jerrold Ellner, MD is Professor and Chief of Infectious Diseases at Boston University School of Medicine and Boston Medical Center. He has studied the immunopathogenesis of TB and TB in HIV through research collaborations in Uganda and Brazil. He has conducted clinical trials of the prevention of treatment of TB as well as the first HIV/AIDS Vaccine Trial in Africa. His research group was the first to show that TB accelerated the course of HIV infection by activating viral replication in latently infected cells. He was one of the principal architects of the Uganda-Case Western Reserve University Research Collaboration, a founding member of the Academic Alliance for AIDS Prevention and Care in Africa which developed the Infectious Diseases Institute at Makerere University, and the founding director of the TB Research Unit at Case Western Reserve University. He is PI of an International Collaboration for Infectious Diseases Research (ICIDR) program in Brazil and the TB – Clinical Diagnostics Research Consortium (CDRC). He has authored more than 250 publications on TB and has trained a number of current academic leaders in infectious diseases.
- Section Chief of Infectious Diseases, Infectious Diseases, Medicine, Boston University School of Medicine
- Active Staff Privileges, Infectious Diseases, Medicine, Boston Medical Center
- Johns Hopkins University School of Medicine, MD
- Cornell University, AB
- Published on 7/16/2018
Choi SW, Gu Y, Peters RS, Salgame P, Ellner JJ, Timmins GS, Deretic V. Ambroxol induces autophagy and potentiates Rifampin antimycobacterial activity. Antimicrob Agents Chemother. 2018 Jul 16. PMID: 30012752.
- Published on 7/13/2018
Geadas C, Acuna-Villaorduna C, Mercier G, Kleinman MB, Horsburgh CR, Ellner JJ, Jacobson KR. FDG-PET/CT activity leads to the diagnosis of unsuspected TB: a retrospective study. BMC Res Notes. 2018 Jul 13; 11(1):464. PMID: 30001743.
- Published on 6/8/2018
Fernandes P, Ma Y, Gaeddert M, Tsacogianis T, Marques-Rodrigues P, Fregona G, Loomans A, Jones-López EC, Dietze R, Ellner JJ, White LF, Hochberg NS. Sex and age differences in Mycobacterium tuberculosis infection in Brazil. Epidemiol Infect. 2018 Jun 08; 1-8. PMID: 29880067.
- Published on 5/15/2018
Verma S, Du P, Nakanjako D, Hermans S, Briggs J, Nakiyingi L, Ellner JJ, Manabe YC, Salgame P. "Tuberculosis in advanced HIV infection is associated with increased expression of IFN? and its downstream targets". BMC Infect Dis. 2018 May 15; 18(1):220. PMID: 29764370.
- Published on 4/1/2018
Freiman JM, Jacobson KR, Muyindike WR, Horsburgh CR, Ellner JJ, Hahn JA, Linas BP. Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis. J Acquir Immune Defic Syndr. 2018 Apr 01; 77(4):405-412. PMID: 29239900.
- Published on 1/31/2018
Leong S, Zhao Y, Joseph NM, Hochberg NS, Sarkar S, Pleskunas J, Hom D, Lakshminarayanan S, Horsburgh CR, Roy G, Ellner JJ, Johnson WE, Salgame P. Existing blood transcriptional classifiers accurately discriminate active tuberculosis from latent infection in individuals from south India. Tuberculosis (Edinb). 2018 Mar; 109:41-51. PMID: 29559120.
- Published on 1/18/2018
Acuña-Villaorduña C, Jones-López EC, Fregona G, Marques-Rodrigues P, Gaeddert M, Geadas C, Hadad DJ, White LF, Pereira Dutra Molina L, Vinhas S, Ribeiro-Rodrigues R, Salgame P, Palaci M, Alland D, Ellner JJ, Dietze R. Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease. Eur Respir J. 2018 Jan; 51(1). PMID: 29348181.
- Published on 1/1/2018
Nonyane BAS, Nicol MP, Andreas NJ, Rimmele S, Schneiderhan-Marra N, Workman LJ, Perkins MD, Joos T, Broger T, Ellner JJ, Alland D, Kampmann B, Dorman SE, Zar HJ. Serologic Responses in Childhood Pulmonary Tuberculosis. Pediatr Infect Dis J. 2018 Jan; 37(1):1-9. PMID: 28719497.
- Published on 11/30/2017
Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, Bablishvili N, Stevens W, Scott L, Rodrigues C, Kazi MI, Joloba M, Nakiyingi L, Nicol MP, Ghebrekristos Y, Anyango I, Murithi W, Dietze R, Lyrio Peres R, Skrahina A, Auchynka V, Chopra KK, Hanif M, Liu X, Yuan X, Boehme CC, Ellner JJ, Denkinger CM. Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2018 Jan; 18(1):76-84. PMID: 29198911.
- Published on 9/14/2017
Xie YL, Chakravorty S, Armstrong DT, Hall SL, Via LE, Song T, Yuan X, Mo X, Zhu H, Xu P, Gao Q, Lee M, Lee J, Smith LE, Chen RY, Joh JS, Cho Y, Liu X, Ruan X, Liang L, Dharan N, Cho SN, Barry CE, Ellner JJ, Dorman SE, Alland D. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis. N Engl J Med. 2017 09 14; 377(11):1043-1054. PMID: 28902596.
View 318 more publications: View full profile at BUMC